Kennedy Schaal

Kennedy Schaal

Founder & CEO Rejuve.Bio

Kennedy Schaal is a biologist and biotechnology executive whose work sits at the forefront of longevity science, applied genomics, and artificial intelligence. She is the Founder and CEO of Rejuve.Bio, a longevity research and technology company developing AI-driven systems to model aging biology and accelerate the discovery of interventions that extend healthy human lifespan.

Kennedy received her training in evolutionary biology at the University of California, Irvine, where she studied under pioneering aging researcher Dr. Michael Rose. In the Rose Lab, she led experimental work on Methuselah flies, a selectively bred Drosophila melanogaster model exhibiting extreme lifespan extension and enhanced stress resistance. This research provided early insight into the evolutionary and genetic mechanisms underlying longevity and shaped her enduring focus on selection, robustness, and systems-level aging biology.
Over the course of her career, Kennedy has contributed to and overseen research spanning genomic selection, transgenic disease models, neurodegeneration, and multi-path longevity interventions. She is a multi-published scientist and has directed experimental programs integrating molecular biology, phenotype analysis, and translational study design.

At Rejuve.Bio, Kennedy leads the development of Mozi, an AI co-scientist platform that integrates multi-omics data, longitudinal clinical signals, and mechanistic biological knowledge into interpretable causal models of aging. Her work emphasizes moving beyond statistical association toward explainable, biologically grounded hypotheses that can guide experimental validation and clinical decision-making.

Kennedy is widely recognized as a thought leader in AI-enabled longevity science and is a frequent speaker at international conferences across aging research, biotechnology, and artificial intelligence. Kennedy sees aging not as an immutable fate, but as a complex biological system, one that can be understood, modeled, and ultimately engineered toward longer, healthier lives.

back to top